Document is current
Any future updates will be listed below
-
Authors
Kostecka, Laurie G. https://orcid.org/0000-0003-2124-3485
Olseen, Athen
Kang, KiChang
Torga, Gonzalo
Pienta, Kenneth J.
Amend, Sarah R.
-
Funding
Funding for this research was provided by:
Nanotechnology for Cancer Research Program
Patrick C. Walsh Prostate Cancer Research Fund
Prostate Cancer Foundation
National Cancer Institute (U54CA143803)
National Cancer Institute (CA163124)
National Cancer Institute (CA093900)
National Cancer Institute (CA143055)
Prostate Cancer Foundation
- License Information
-
More Information
Article History
Received: 12 November 2020
Accepted: 9 March 2021
First Online: 24 March 2021
Declarations
:
: KJP discloses that he is a consultant to Cue Biopharma, Inc. as well as a founder and equity holder in Keystone Biopharma, Inc. No other authors have conflicts of interest to disclose.
: Not Applicable.
: Not Applicable.
: All authors consent to the publication of this manuscript.
